NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (the “Company”) announced today that it has completed its previously announced offer to exchange (the “Exchange Offer”) up to $250,000,000 in aggregate principal amount of its currently outstanding 9.750% Senior Notes due 2017 (the “Initial Notes”) for an equal aggregate principal amount of its new 9.750% Senior Notes due 2017 (the “New Notes”) that have been registered under the Securities Act of 1933, as amended (the “Securities Act”).
